Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin.

Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin. Liver Transpl. 2001 Oct; 7(10):863-9.

View in: PubMed

subject areas

Administration, Oral
Adult
Antiviral Agents
Chi-Square Distribution
Drug Administration Schedule
Drug Therapy, Combination
Female
Follow-Up Studies
Hepatitis C, Chronic
Humans
Injections, Subcutaneous
Interferon-alpha
Liver Cirrhosis, Biliary
Liver Transplantation
Male
Middle Aged
Probability
Recurrence
Ribavirin
Treatment Outcome

authors with profiles

John Fung